Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Living Long & Lean

Description

Triple L arose from the research work related to the development of new therapies for primary mitochondrial disorders. Since mitochondrial dysfunction is also an important pathological feature in more common diseases, including obesity and NAFLD, one of our therapeutic approaches was identified as an important modulator of the energy metabolism of white adipose tissue (WAT). Thus, we patent TL-100 as an option for the reduction in the content of WAT, and to treat obesity-related conditions. Based on the TL-100 activity, we are currently working in the development of different products dedicated to the control of the body weight, and the treatment of obesity and NAFLD. To achieve this goal, Triple L is composed by scientists with expertise in different fields in the biomedical domain.

Current needs

Triple L is made up of experienced and young scientists, who continue developing the I+D strategy around the mechanisms of action of TL-100. Triple L has also the advice of the TTO of the University of Granada and some consulting companies. Additionally, we are creating the scientific advisory board. To exploit the therapeutic potential of TL-100 based products, Triple L requires a CEO with a qualified expertise to develop the business plan. We would also need experts in developing clinical trials, particularly in the field of metabolic diseases. Triple L is also opened to consider new scientific collaborations to explore new formulations and chemical entities. Finally, to develop all required regulatory and clinical aspects and reach the market we would need the participation of investors interested in new business opportunities based on the development of novel therapies for metabolic diseases.

Meet the team

Full Professor of Physiology

Postdoctoral researcher

Assistant Professor of Biochemistry & Molecular Biology

Assistant Professor of Physiology

PhD student

PhD student

PhD student

Postdoctoral researcher

Postdoctoral researcher

Actuación del Campus de excelencia cofinanciadas por la Unión Europea a través del Fondo Europeo de Desarrollo Regional (FEDER) y la Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía.

Proyecto Singular ILIBERIS: Actuaciones Singulares de Transferencia de Conocimiento en el CEI BIOTIC.

Marco por el que se impulsa el desarrollo de Proyectos Singulares de actuaciones de transferencia en los Campus de Excelencia Internacional en las áreas de la Estrategia de Investigación e Innovación para la Especialización Inteligente de Andalucía (RIS3) con cargo al Programa Operativo FEDER 2014-2020 de Andalucía.